Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorpo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorp ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ___________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR Delaware 86-1243837 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 210 Barton Springs Road Suite 300 Austin Texas (Address of Principal Executive Offices) 78704 Commission file number 001-40046 ☐ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 210 Barton Springs Road Suite 300 Austin, Texas (Address of Principal Executive Offices) 78704 (Zip Code) (512) 402-5233 Registrant's telephone number, including area code Securities ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other jur ...

Core Scientific, Inc. (NASDAQ:CORZ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Steven Gitlin – Senior Vice President-Investor Relations Mike Levitt – Chief Executive Officer Denise Sterling – Chief Financial Officer Conference Call Participants Lucas Pipes – B. Riley Chris Brendler – D.A. Davidson Stephen Glagola – Cowen Kevin Dede – H.C. Wainwright Steven Gitlin Good afternoon, ladies and gentlemen, and welcome to Core Scientific’s Second Quarter Fiscal Year 2022 Earni ...

| --- | --- | --- | |--------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | Second Quarter Fiscal Year | | | | 2022 Earnings Presentation August 11, 2022 | | | | AUG 11, 2022 | | 1 | Legal Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements'' within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use o ...

| --- | --- | --- | |----------------------------|-------|-------| | | | | | | | | | | | | | First Quarter Fiscal Year | | | | 2022 Earnings Presentation | | | | May 12, 2022 | | | | MAY 12, 2022 | | 1 | Legal Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements'' within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) Delaware 86-1243837 (State or other ju ...

Core Scientific, Inc. (NASDAQ:CORZ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Steven Gitlin - Senior Vice President Investor Relations Mike Levitt - Chief Executive Officer Denise Sterling - Chief Financial Officer Conference Call Participants Chris Brendler - D.A. Davidson Lucas Pipes - B. Riley Securities Tyler DiMatteo - BTIG Steven Gitlin Good afternoon, ladies and gentlemen, and welcome to Core Scientific’s First Quarter Fiscal Year 2022 Earnings Call. This is Steven ...